These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6757396)

  • 1. Comparative histology of the mouse bladder following initial infection and re-infection with Escherichia coli.
    Sivan Y; Griffel B; Medalia O; Aronson M
    J Pathol; 1982 Dec; 138(4):353-64. PubMed ID: 6757396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil recruitment and resistance to urinary tract infection.
    Haraoka M; Hang L; Frendéus B; Godaly G; Burdick M; Strieter R; Svanborg C
    J Infect Dis; 1999 Oct; 180(4):1220-9. PubMed ID: 10479151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice.
    Kerrn MB; Struve C; Blom J; Frimodt-Møller N; Krogfelt KA
    J Antimicrob Chemother; 2005 Mar; 55(3):383-6. PubMed ID: 15681580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
    Artym J; Zimecki M; Kruzel ML
    Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
    Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
    Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiology. Pods invade infected bladders.
    Ferber D
    Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
    [No Abstract]   [Full Text] [Related]  

  • 7. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.
    Bishop BL; Duncan MJ; Song J; Li G; Zaas D; Abraham SN
    Nat Med; 2007 May; 13(5):625-30. PubMed ID: 17417648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
    Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory plasma cell infiltration of the urinary bladder in the aging C57BL/Icrfa(t) mouse.
    Phillips JI
    Invest Urol; 1981 Sep; 19(2):75-8. PubMed ID: 7196895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-3-dependent apoptosis in Escherichia coli-infected urothelium: involvement of inducible nitric oxide synthase.
    Andersson M; Poljakovic M; Persson K
    BJU Int; 2006 Jul; 98(1):160-5. PubMed ID: 16831162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder infection in the menopausal monkey.
    Roberts JA; Kaack MB; Harrison RM; Klopp R; Ershler W
    J Urol; 1999 Jul; 162(1):254-7. PubMed ID: 10379796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli.
    Malaviya R; Ikeda T; Abraham SN; Malaviya R
    Immunol Lett; 2004 Feb; 91(2-3):103-11. PubMed ID: 15019277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on infectious mechanism of type 1 fimbriated Escherichia coli in experimental cystitis of mice].
    Jie L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):250-4. PubMed ID: 7909502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of the vesical wall to bacterial penetration: resistance to attachment, desquamation and leukocytic activity.
    Orikasa S; Hinman F
    Trans Am Assoc Genitourin Surg; 1977; 69():52-60. PubMed ID: 369095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and histologic evaluation of the urinary bladder wall after group A streptococcal infection.
    Harn SD; Keutel HJ; Weaver RG
    Invest Urol; 1973 Jul; 11(1):55-64. PubMed ID: 4125064
    [No Abstract]   [Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody coating of bacteria in experimental infection of the urinary bladder.
    Riedasch G; Schneider E; Ritz E; Bersch W; Möhring K
    Invest Urol; 1981 Jan; 18(4):247-50. PubMed ID: 7005181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of granulopoiesis and distribution of granulocytes in early phase of bacterial infection.
    Hartmann DW; Entringer MA; Robinson WA; Vasil ML; Drebing CJ; Morton NJ; True L
    J Cell Physiol; 1981 Oct; 109(1):17-24. PubMed ID: 7035470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.